Agilent to Debut New CGH and SNP Arrays to Support Cyto, Cancer Research
September 14, 2010
Agilent to Debut New CGH and SNP Arrays to Support Cyto, Cancer Research
The addition of SNP content will further enable cytogeneticists using Agilent arrays to detect constitutional abnormalities, and could help make Agilent more competitive against firms like Affymetrix and Illumina that currently sell SNP platforms for cytogenetic research.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Affy Files CytoScan with FDA, Plans 'Aggressive' Marketing Campaign to Grow Cyto Business
February 19, 2013 / BioArray News - After 'Pivotal' 2012, Affy Looks to CytoScan, Axiom Genotyping Products to Drive Future Growth
February 5, 2013 / BioArray News - Cytogeneticists Say Platform Choice a Question of Personal Preference, Circumstance
August 21, 2012 / BioArray News - Roche NimbleGen to Expand CGH Array Menu, Plans Additional High-Density Chips
March 29, 2011 / BioArray News - BlueGnome Debuts Cancer Cytogenomics Microarray Consortium-Designed Arrays
December 21, 2010 / BioArray News